MetaCap

Oaktree Acquisition III Life Sciences (OACC) Stock Chart

NASDAQ: OACCFinanceBlank ChecksUSD

10.760.00 (0.00%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

OACC technical summary

OACC is trading 0.0% below its 50-day simple moving average of $10.76 and 0.7% above its 200-day average of $10.68. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 46.5, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $10.50 (Oct 21, 2025) to $10.88 (Jul 30, 2026); the current price sits 69% of the way from the low to the high. Annualized 30-day volatility is 2.4%. Based on the last session's high, low and close, the classic pivot point is $10.76, with first resistance at $10.76 and first support at $10.75.

These indicators describe past price behavior for Oaktree Acquisition III Life Sciences; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
10.88 (Jul 30)
1Y low
10.50 (Oct 21)
Last close
10.76

OACC price performance

1 week

-0.19%

1 month

-0.37%

3 months

+0.65%

6 months

+1.51%

Year to date

+1.70%

1 year

+1.91%

OACC price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day10.76Price above10.76Price below
10-day10.77Price below10.77Price below
20-day10.77Price below10.77Price below
50-day10.76Price below10.76Price above
100-day10.72Price above10.73Price above
200-day10.68Price above10.69Price above

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)10.77
Resistance 2 (R2)10.77
Resistance 1 (R1)10.76
Pivot point10.76
Support 1 (S1)10.75
Support 2 (S2)10.75
Support 3 (S3)10.74

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis